Executive leadership at Healthcare Triangle.
Board of directors at Healthcare Triangle.
Research analysts covering Healthcare Triangle.
Recent press releases and 8-K filings for HCTI.
Healthcare Triangle, Inc. Announces 1-for-60 Reverse Stock Split
HCTI
Delisting/Listing Issues
Proxy Vote Outcomes
- Healthcare Triangle, Inc. (HCTI) will implement a 1-for-60 reverse stock split of its common stock, effective February 10, 2026, with post-split trading commencing on the Nasdaq Capital Market on the same day.
- The primary goal of this reverse stock split is to increase the price per share of the Company's common stock and to regain compliance with the Nasdaq Capital Market's $1.00 minimum bid price requirement.
- The reverse stock split, which was approved by stockholders on February 2, 2026, will reduce the Company's outstanding common stock from approximately 45,417,091 shares to approximately 756,952 shares.
- Stockholders who would otherwise be entitled to receive a fractional share will be rounded up at a participant level.
18 hours ago
Healthcare Triangle Subsidiary QuantumNexis Forms Joint Venture in Saudi Arabia
HCTI
New Projects/Investments
Product Launch
- Healthcare Triangle, Inc.'s (HCTI) subsidiary, QuantumNexis, has formed a Joint Venture with Golden Code Holdings to enter the Saudi Arabian healthcare market.
- This partnership aims to address the $70 billion Saudi Arabian Healthcare Market by 2030 and aligns with Saudi Vision 2030 for digital health transformation.
- QuantumNexis will introduce its advanced digital health platforms, including Ezovion, Ziloy.ai, and Readabl.ai, to the region.
- The Joint Venture will establish QuantumNexis' presence in Saudi Arabia as its Middle East hub for digital health innovation.
2 days ago
Healthcare Triangle Partners with Better.care for Global Expansion
HCTI
New Projects/Investments
Product Launch
- Healthcare Triangle (HCTI) announced a Development Program Agreement with Better, a global digital healthcare platform provider, on January 29, 2026.
- This collaboration positions HCTI as a preferred service provider for Better's platform across high-growth healthcare markets in Europe, Southeast Asia, the Middle East, and Africa.
- Under the agreement, HCTI and its subsidiary QuantumNexis will gain access to training and certification programs to build expertise and delivery capabilities using Better's advanced platform.
- The partnership targets global market growth in Southeast Asia, specifically India, Malaysia, Indonesia, and the Philippines, and in the Middle East & Africa, including Saudi Arabia and multiple African markets.
Jan 29, 2026, 1:18 PM
Healthcare Triangle, Inc. Announces Acquisition of Teyame AI LLC
HCTI
M&A
New Projects/Investments
Guidance Update
- Healthcare Triangle, Inc. (HCTI) has entered into a definitive agreement to acquire Teyame AI LLC, which includes Teyame 360 SL and Datono Mediacion SL, with the transaction deemed effective as of January 1, 2026.
- The total consideration for the acquisition is up to approximately $50 million, comprising cash, common stock, non-voting convertible preferred stock, and contingent earnout-based equity.
- The acquired assets are forecasted to generate $38 million in incremental NTM Revenue and $5 million in incremental NTM EBITDA.
- For fiscal year 2025, the acquired assets generated approximately $32 million in incremental annual revenue and $3.6 million in incremental EBITDA.
- This strategic acquisition is expected to enhance HCTI's financial performance and shareholder value by expanding its AI-powered customer and patient engagement solutions and SaaS footprint in Europe and Latin America.
Jan 28, 2026, 3:03 PM
Healthcare Triangle Signs Definitive Agreement for AI-Powered CX Acquisition
HCTI
M&A
New Projects/Investments
Convertible Preferred Issuance
- Healthcare Triangle, Inc. (HCTI) has signed a definitive agreement to acquire the assets of Teyame 360 SL and Datono Mediacion SL, which are Spain-based leaders in AI-powered omnichannel customer experience (CX) solutions.
- The proposed transaction contemplates up to approximately $50 million of total consideration, consisting of cash, common stock, non-voting convertible preferred stock, and contingent earnout-based equity.
- The acquisition is forecasted to generate $38 million in incremental NTM Revenue and $5 million in incremental NTM EBITDA.
- The transaction is anticipated to close on January 29, 2026, with an effective date of January 1, 2026, subject to shareholder approval and other customary closing conditions.
- This strategic move aims to position HCTI as a global force in AI-powered customer and patient engagement, expanding its SaaS footprint into Europe and Latin America.
Jan 22, 2026, 1:10 PM
Healthcare Triangle, Inc. Signs Advance Agreement for AI Customer Engagement Business Acquisition
HCTI
M&A
New Projects/Investments
Convertible Preferred Issuance
- Healthcare Triangle, Inc. (HCTI) entered into an Advance Agreement on December 5, 2025, with Teyame AI LLC for the proposed acquisition of Teyame 360 SL and Datono Mediacion SL, a Spain-based AI-powered omnichannel customer experience business.
- The total consideration for the acquisition is up to approximately $50 million, consisting of $15 million in cash, $6 million in common stock, $24 million in non-voting convertible preferred stock (post-closing), and $5 million in non-voting convertible preferred stock (management earnout).
- HCTI agreed to pay an advance of $3 million in cash to Teyame on or before December 8, 2025, with the transaction targeting a closing on or before February 16, 2026.
- The acquired assets are expected to generate approximately $34 million in incremental annual revenue and $4.2 million in incremental EBITDA for fiscal year 2025.
Dec 10, 2025, 2:00 PM
HCTI Signs Advance Agreement for AI Customer Engagement Business Acquisition
HCTI
M&A
New Projects/Investments
Convertible Preferred Issuance
- Healthcare Triangle, Inc. (HCTI) has entered into an Advance Agreement to acquire Teyame 360 SL and Datono Mediacion SL, a Spain-based leader in AI-powered omnichannel customer experience (CX) solutions.
- The proposed acquisition is valued at up to approximately $50 million in total consideration, which includes cash, common stock, non-voting convertible preferred stock, and contingent earnout-based equity.
- The acquired assets are expected to generate approximately $34 million in incremental annual revenue and $4.2 million in incremental EBITDA for fiscal year 2025.
- The transaction is anticipated to close in the first quarter of 2026, subject to definitive agreements and other customary closing conditions, aiming to position HCTI as a global force in AI-powered customer and patient engagement.
Dec 10, 2025, 12:30 PM
Healthcare Triangle, Inc. Issues Convertible Promissory Notes
HCTI
Debt Issuance
Convertible Preferred Issuance
- Healthcare Triangle, Inc. entered into a Securities Purchase Agreement on November 20, 2025, to issue senior unsecured convertible promissory notes with an aggregate original principal amount of up to $15,000,000.
- The first tranche of notes, with an original principal amount of $7,500,000, was sold for $6,000,000 in gross proceeds, reflecting a 20% original issue discount.
- These notes mature on November 20, 2026, and are convertible into common stock at a price that is the greater of 80% of the lowest Closing Price during the five trading days preceding conversion or $0.38 per share.
- The notes rank senior to all future indebtedness and bear an 18% per annum past due interest rate.
- The $6,000,000 gross proceeds will be used for general working capital and to repay certain liabilities.
Nov 21, 2025, 9:57 PM
Healthcare Triangle, Inc. enters into "at the market" offering agreement
HCTI
- Healthcare Triangle, Inc. (HCTI) entered into a Sales Agreement with Spartan Capital Securities, LLC on November 18, 2025, to establish an "at the market offering" program for its common stock.
- Under this agreement, HCTI may issue and sell shares of its common stock with an aggregate market value of up to $20,000,000.
- Spartan Capital Securities, LLC will serve as the sales agent and receive 3.0% of the gross sales price for all shares sold through them.
- The Company retains the discretion to set sales parameters, including the number of shares and timing, and has no obligation to sell any shares under the agreement.
Nov 19, 2025, 7:27 PM
Healthcare Triangle Signs LOI to Acquire Teyame.AI, Boosting AI Capabilities and Expected 2025 Revenue
HCTI
M&A
New Projects/Investments
Revenue Acceleration/Inflection
- Healthcare Triangle, Inc. (HCTI) has signed a non-binding Letter of Intent (LOI) to acquire Teyame.AI LLC, a Spain-based leader in AI-powered omnichannel customer experience solutions.
- This acquisition is projected to add approximately $34 million in incremental annual revenue and $4.2 million in incremental EBITDA for HCTI in fiscal year 2025.
- The strategic move aims to position HCTI as a global force in AI-powered customer and patient engagement, expanding its international market reach and integrating Teyame's advanced AI automation platform with HCTI's healthcare technology expertise.
Oct 9, 2025, 12:28 PM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more